CIK 0000914475
- Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330525145
- Phone
- +1 858-617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-09 | POPS RICHARD F Director | Sale | −7,500 | $76.29 | $572K | 29,512 |
| 2022-05-09 | POPS RICHARD F Director | Option exercise | +7,500 | $6.66 | $50K | 37,012 |
| 2022-05-09 | POPS RICHARD F Director | Sale | −7,500 | $76.30 | $572K | 29,512 |
| 2022-05-09 | POPS RICHARD F Director | Option exercise · Non-Qualified Stock Option | −7,500 | $6.66 | $50K | 7,500 |
| 2022-05-09 | POPS RICHARD F Director | Option exercise · Non-Qualified Stock Option | −7,500 | $6.66 | $50K | 0 |
| 2022-04-25 | LYONS GARY A Director | Option exercise | +15,000 | $6.66 | $100K | 223,697 |
| 2022-04-25 | LYONS GARY A Director | Sale | −15,000 | $92.76 | $1.4M | 208,697 |
| 2022-04-25 | LYONS GARY A Director | Option exercise · Non-Qualified Stock Option | −15,000 | $6.66 | $100K | 0 |
| 2022-04-01 | RASTETTER WILLIAM H Director | Option exercise | +20,000 | $6.66 | $133K | 44,750 |
| 2022-04-01 | RASTETTER WILLIAM H Director | Sale | −10,728 | $94.93 | $1.0M | 34,022 |
| 2022-04-01 | RASTETTER WILLIAM H Director | Option exercise · Non-Qualified Stock Option | −20,000 | $6.66 | $133K | 0 |
| 2022-03-22 | Lippoldt Darin Chief Legal Officer | Sale | −8,455 | $95.05 | $804K | 29,396 |
| 2022-03-18 | Lippoldt Darin Chief Legal Officer | Sale | −300 | $95.00 | $29K | 37,851 |
| 2022-02-08 | Boyer David W. Chief Corp. Affairs Officer | Sale | −700 | $79.62 | $56K | 2,919 |
| 2022-02-08 | ROBERTS EIRY Chief Medical Officer | Sale | −980 | $79.52 | $78K | 24,625 |
| 2022-02-08 | Lloyd-Smith Malcolm Chief Regulatory Officer | Sale | −701 | $79.53 | $56K | 18,731 |
| 2022-02-08 | Lippoldt Darin Chief Legal Officer | Sale | −911 | $79.51 | $72K | 38,112 |
| 2022-02-08 | GORMAN KEVIN CHARLES Chief Executive Officer | Sale | −2,274 | $79.49 | $181K | 462,844 |
| 2022-02-08 | Gano Kyle Chief Business Development Off | Sale | −980 | $79.67 | $78K | 111,173 |
| 2022-02-08 | Cooke Julie Chief Human Resources Officer | Sale | −700 | $79.56 | $56K | 17,411 |
Page 54 of 62 · 1,221 trades